This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hodgson, N. C. Articles by Solorzano, C. C. Search for Related Content PubMed PubMed Citation Articles by Hodgson, N. C. Articles by Solorzano, C. C.

Thyroid Cancer: Is the Incidence Still Increasing?

From The Dewitt Daughtry Family Department of Surgery (NCH, CCS), Division of Surgical Oncology, University of Miami School of Medicine; and the Florida Cancer Data System (JB), Miami, Florida.

Correspondence: Address correspondence and reprint requests to: Carmen C. Solorzano, MD, Sylvester Cancer Center (M-875), 1475 NW 12th Avenue, Miami, FL 33136; Fax: 305-243-4221; e-mail: csolorzano{at}med.miami.edu

Background: The objective of this study was to define the epidemiology of thyroid cancer in our regional population and compare results with Surveillance, Epidemiology, and End Results (SEER) Program cancer registry trends.

Methods: Thyroid cancer cases diagnosed between 1990 and 2000 were identified in the Florida Cancer Data System (FCDS). Overall, gender-specific, age-specific, and stage-specific incidence rates were calculated. All rates are per 100,000 and age-adjusted to the 2000 U.S. standard population. Estimated Annual Percent Change (EAPC) was calculated with a linear least-squares model.

Results: Patients with thyroid cancer (n = 8603) were identified in the FCDS registry. Age-adjusted incidence rates increased from 4.2 per 100,000 to 7 per 100,000 in 2000. The EAPC for this period was 5.5% (P < .001). The SEER incidence rates increased from 7.9 to 10.2 per 100,000, and the EAPC was 3.7% (P < .05). Analysis of gender-specific incidence rates showed increases from 6 and 2.2 per 100,000 in 1990 to 10.1 and 3.8 per 100,000 in 2000 among females and males, respectively, with EAPCs of 5.9% (females) and 4.5% (males) (P < .001). With stratification by age group, the highest incidence rates were 9 per 100,000 in the group aged 65 to 84 years and 8.4 per 100,000 in the group aged 45 to 64 years.

Conclusions: Thyroid cancer incidence rates in Florida almost doubled over the 1990–2000 period and are concordant with SEER trends. Etiologic studies addressing temporal changes in reproductive factors, more intensive diagnostic activities, and changes in histological criteria are warranted.

Key Words: Epidemiology • Incidence • Thyroid cancer

This article has been cited by other articles:

				M. Perrino, G. Vannucchi, L. Vicentini, G. Cantoni, D. Dazzi, C. Colombo, M. Rodari, A. Chiti, P. Beck-Peccoz, and L. Fugazzola Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers <=2 cm Endocr. Relat. Cancer, March 1, 2009; 16(1): 201 - 210. [Abstract] [Full Text] [PDF]

				G. Sassolas, Z. Hafdi-Nejjari, L. Remontet, N. Bossard, A. Belot, N. Berger-Dutrieux, M. Decaussin-Petrucci, C. Bournaud, J. L. Peix, J. Orgiazzi, et al. Thyroid cancer: is the incidence rise abating? Eur. J. Endocrinol., January 1, 2009; 160(1): 71 - 79. [Abstract] [Full Text] [PDF]

				L. Brunese, A. Romeo, S. Iorio, G. Napolitano, S. Fucili, P. Zeppa, G. Vallone, G. Lombardi, A. Bellastella, B. Biondi, et al. Thyroid B-flow twinkling sign: a new feature of papillary cancer Eur. J. Endocrinol., October 1, 2008; 159(4): 447 - 451. [Abstract] [Full Text] [PDF]

				W. Mendez, S. E. Rodgers, J. I. Lew, R. Montano, and C. C. Solorzano Role of Surgeon-Performed Ultrasound in Predicting Malignancy in Patients with Indeterminate Thyroid Nodules Ann. Surg. Oncol., September 1, 2008; 15(9): 2487 - 2492. [Abstract] [Full Text] [PDF]

				L. G. T. Morris, A. G. Sikora, D. Myssiorek, and M. D. DeLacure The Basis of Racial Differences in the Incidence of Thyroid Cancer Ann. Surg. Oncol., April 1, 2008; 15(4): 1169 - 1176. [Abstract] [Full Text] [PDF]

				W. D.T. Kent MSc MD, S. F. Hall MSc MD, P. A. Isotalo MD, R. L. Houlden MD, R. L. George MD, and P. A. Groome PhD Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease Can. Med. Assoc. J., November 20, 2007; 177(11): 1357 - 1361. [Abstract] [Full Text] [PDF]

				R. Guignard, T. Truong, Y. Rougier, D. Baron-Dubourdieu, and P. Guenel Alcohol Drinking, Tobacco Smoking, and Anthropometric Characteristics as Risk Factors for Thyroid Cancer: A Countrywide Case-Control Study in New Caledonia Am. J. Epidemiol., November 15, 2007; 166(10): 1140 - 1149. [Abstract] [Full Text] [PDF]

				B. H.-H. Lang, C.-Y. Lo, W.-F. Chan, K.-Y. Lam, and K.-Y. Wan Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging Ann. Surg. Oncol., February 1, 2007; 14(2): 730 - 738. [Abstract] [Full Text] [PDF]

				M. W Yeh, J.-P. Rougier, J.-W. Park, Q.-Y. Duh, M. Wong, Z. Werb, and O. H Clark Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A Endocr. Relat. Cancer, December 1, 2006; 13(4): 1173 - 1183. [Abstract] [Full Text] [PDF]

				F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J. W A Smit, W. Wiersinga, and the European Thyroid Cancer Taskforce European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol., June 1, 2006; 154(6): 787 - 803. [Full Text] [PDF]

				L. Davies and H. G. Welch Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, May 10, 2006; 295(18): 2164 - 2167. [Abstract] [Full Text] [PDF]